{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:07Z","timestamp":1791388987072,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.ejphar.2007.05.045","type":"journal-article","created":{"date-parts":[[2007,6,11]],"date-time":"2007-06-11T13:39:51Z","timestamp":1181569191000},"page":"89-96","source":"Crossref","is-referenced-by-count":77,"title":["Central \u03ba-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: Behavioral and BDNF mRNA expression studies"],"prefix":"10.1016","volume":"570","author":[{"given":"Huina","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Gong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley J.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Chuan","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.05.045_bib1","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/j.1476-5381.1991.tb09869.x","article-title":"Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist","volume":"103","author":"Birch","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","article-title":"BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis","volume":"76","author":"Bramham","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","article-title":"Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats","volume":"26","author":"Broom","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.045_bib4","first-page":"1269","article-title":"Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys","volume":"267","author":"Butelman","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib6","first-page":"852","article-title":"A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86","volume":"267","author":"Chang","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(01)01083-6","article-title":"Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication","volume":"50","author":"Chen","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.05.045_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.lfs.2005.04.084","article-title":"The dynamic relationship between mu and kappa opioid receptors in body temperature regulation","volume":"78","author":"Chen","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bjp.0703311","article-title":"Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery","volume":"130","author":"de Ligt","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biopsych.2004.02.033","article-title":"Depression: a case of neuronal life and death?","volume":"56","author":"Duman","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.05.045_bib12","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model of stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.05.045_bib13","first-page":"30","article-title":"Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo","volume":"316","author":"Endoh","year":"1992","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1600-0773.1990.tb00728.x","article-title":"Kappa-opioid receptor agonists differentially affect the release of neurohypophysial hormones","volume":"66","author":"Fjalland","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainresrev.2004.02.003","article-title":"Critical role of brain-derived neurotrophic factor in mood disorders","volume":"45","author":"Hashimoto","year":"2004","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2007.05.045_bib16","first-page":"1237","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test","volume":"260","author":"Horan","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/0896-6273(91)90234-Q","article-title":"BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF","volume":"6","author":"Isackson","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2007.05.045_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.brainres.2004.07.065","article-title":"The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels","volume":"22","author":"Jacobsen","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.05.045_bib19","first-page":"815","article-title":"Nor-binaltorphimine: an ultra-long acting kappa-opioid antagonist in pigeons","volume":"6","author":"Jewett","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0014-2999(92)90055-9","article-title":"Long term kappa-opioid receptor blockade following nor-binaltorphimine","volume":"215","author":"Jones","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib21","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-3565(24)35216-4","article-title":"Intracisternal nor-binaltorphimine distinguishes central and peripheral \u03ba-opioid antinociception in rhesus monkeys","volume":"291","author":"Ko","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0006-8993(03)02938-X","article-title":"Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys","volume":"982","author":"Ko","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.05.045_bib23","first-page":"89","article-title":"A kappa opioid effect: increased urination in the rat","volume":"224","author":"Leander","year":"1983","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0006-3223(92)90070-G","article-title":"Signal-transducing G proteins and antidepressant drugs: evidence for modulation of alpha subunit gene expression in rat brain","volume":"32","author":"Lesch","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.05.045_bib25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib26","first-page":"334","article-title":"Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli","volume":"251","author":"Millan","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-6147(00)88963-4","article-title":"Inverse agonism: pharmacological curiosity or potential therapeutic strategy?","volume":"16","author":"Milligan","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib28","doi-asserted-by":"crossref","first-page":"10883","DOI":"10.1523\/JNEUROSCI.22-24-10883.2002","article-title":"Inhibition of cAMP response element binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect","volume":"22","author":"Newton","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib29","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1523\/JNEUROSCI.15-11-07539.1995","article-title":"Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments","volume":"15","author":"Nibuya","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib30","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.ejphar.2007.05.045_bib31","first-page":"495","article-title":"Opioids and rate of positively reinforced behavior: III. Antagonism by the long-lasting kappa antagonist nor-binaltorphimine","volume":"6","author":"Picker","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib32","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1523\/JNEUROSCI.21-18-07397.2001","article-title":"Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element binding protein expression in nucleus accumbens","volume":"21","author":"Pliakas","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib33","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1038\/sj.npp.1300514","article-title":"Hippocampal brain-derived neurotrophic factor expression following treatment with reboxetine, citalopram, and physical exercise","volume":"29","author":"Russo-Neustadt","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.045_bib34","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1176\/appi.ajp.160.8.1516","article-title":"Untreated depression and hippocampal volume loss","volume":"160","author":"Sheline","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.05.045_bib35","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","article-title":"Brain-derived neurotrophic factor produces antidepressant effects in behavioral model of depression","volume":"22","author":"Shirayama","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2007.05.045_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0091-3057(96)00169-4","article-title":"Antidepressant-like effect of brain-derived neurotrophic factor (BDNF)","volume":"56","author":"Siuciak","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.05.045_bib38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1523\/JNEUROSCI.15-03-01768.1995","article-title":"Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus","volume":"15","author":"Smith","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2007.05.045_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0014-2999(94)00449-8","article-title":"Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes","volume":"264","author":"Spanagel","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib40","first-page":"255","article-title":"Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays","volume":"246","author":"Takemori","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib41","first-page":"971","article-title":"Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats","volume":"247","author":"Takemori","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1124\/pr.58.1.7","article-title":"Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical review","volume":"58","author":"Tardito","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2007.05.045_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00213-003-1680-y","article-title":"Effects of \u03ba-opioid receptor ligands on intracranial self-stimulation in rats","volume":"172","author":"Todtenkopf","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.045_bib44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/MN:33:1:017","article-title":"What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development","volume":"33","author":"Tongiorgi","year":"2006","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2007.05.045_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.npp.1300345","article-title":"The \u03b4-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats","volume":"29","author":"Torregrossa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.05.045_bib46","first-page":"959","article-title":"In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats","volume":"271","author":"Walker","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib47","first-page":"1345","article-title":"Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","volume":"273","author":"Walker","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.05.045_bib48","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1460-9568.2006.04621.x","article-title":"Endogenous opioids upregulate brain-derived neurotrophic factor mRNA through \u03b4- and \u03bc-opioid receptors independent of antidepressant-like effects","volume":"23","author":"Zhang","year":"2006","journal-title":"Eur. J. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907006516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907006516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T05:31:38Z","timestamp":1737091898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907006516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":48,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0014299907006516"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.045","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}